Followers | 83 |
Posts | 2557 |
Boards Moderated | 0 |
Alias Born | 06/15/2018 |
Friday, March 22, 2019 6:07:14 PM
It’s just a teeny operation and taking an inordinately long time (for shareholders at least) to get any kind of toehold on the road to commercialization.
Their first product, the bio solar panel worked but didn’t find any kind of market.
A longer lasting battery for (hopefully) not much more cost would certainly find a market. But the tech is super rarefied and we just have no indication if they will ever get there. Bit like investing in a biotech. Could be a patented gold mine or could all collapse late in phase 3.
Recent NEWH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:30:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 10:00:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 08:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:56:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 08:30:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM